Ciprofloxacin Injection 200 mg/100 mL

Trade Name:
Parsacip

Generic Name:
Ciprofloxacin

Composition:
Ciprofloxacin (as lactate) .......................................... 200 mg
Water for Injection ................................................... up to 100 mL

Dosage Form and Packaging

A clear, colorless to light yellow injectable solution supplied in 100 mL glass bottles for intravenous infusion.

Pharmacological Classification:
Antibiotic – Fluoroquinolone group

Indications

Ciprofloxacin is used for the treatment of various bacterial infections, including:

• Respiratory tract infections (bronchitis, pneumonia)
• Urinary tract infections
• Skin and soft tissue infections
• Gastrointestinal infections
• Sepsis
• Bone and joint infections
• Intra-abdominal infections (in combination with metronidazole)

Dosage and Administration

Adults:
400 mg every 12 hours by slow intravenous infusion over 60 minutes.

Children:
10–20 mg/kg body weight every 12 hours (up to a maximum of 400 mg per day).
Dosage may vary depending on infection type, severity, and renal/hepatic function.

Contraindications

• Hypersensitivity to ciprofloxacin or other fluoroquinolones
• Children and adolescents during growth (except special cases)
• Patients with a history of seizures or CNS disorders
• Pregnancy and lactation (unless prescribed by a doctor)

Precautions

• Monitor renal function during therapy
• Avoid direct sunlight exposure (photosensitivity risk)
• Use cautiously with anticonvulsants, NSAIDs, and theophylline
• If severe diarrhea occurs, stop treatment and consult a doctor (possible Clostridium difficile colitis)

Drug Interactions

• Theophylline, cyclosporine, oral anticoagulants, antiarrhythmic drugs (may increase QT prolongation risk)

Possible Side Effects

• Nausea, vomiting, diarrhea
• Headache, dizziness
• Photosensitivity
• Sleep disturbances
• Elevated liver enzymes
• Rare: seizures, severe allergic reactions (anaphylactoid)

Storage Conditions

Store below 25°C, protected from light and freezing.
Do not use after the expiry date.

Dispensing Conditions

Prescription-only medicine.

Manufacturer Information

Parsawa Injectable Solutions Manufacturing Factory
Industrial Park, Phase 3, Sosan 5, Herat, Afghanistan